Search for: "AIPLA" Results 481 - 500 of 752
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2010, 10:37 am by Eric
Three of the briefs, from AIPLA, Audible Magic and Vobile, support neither party. [read post]
27 Dec 2012, 3:17 am by Dennis Crouch
According to the AIPLA 2011 Economic Survey, a novelty search is about $2000, which suggests that Track 1 may be less expensive on average than AE for small entities. [read post]
11 Mar 2008, 3:54 am
The applicant would provide this correction to the claim by submitting an amendment to the application.To estimate the cost of amending an application in order to correct the format of the claim(s), the Office is using unit cost data on amendments from the AIPLA Report of the Economic Survey.3 Based on the AIPLA data, the Office estimates that the cost of filing one amendment to correct the format of the claim(s) is $4,029 (expressed in present value terms using a 7 percent… [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
16 Oct 2006, 9:44 pm
American Intellectual Property Law Association (AIPLA) in Support of Respondent: AIPLA’s brief is a fun read — it starts off with quotes from Billy Wilder and King Solomon, both of which give us pause on the question of hindsight. [read post]
24 Sep 2017, 5:04 pm by Dennis Crouch
In June, Helsinn filed for en banc review with support from the big players: Helsinn-Petition Teva-Response AIPLA (prior “on sale” activity must make the invention available to the public) BIO (negative consequences will flow from the panel decision) Boston (court should take the case and decide the issue) IPO (court should rule en banc, decision is contrary to MedCo) PhRMA (the legislative history “reflects [Congress’s]… [read post]
27 Mar 2008, 11:01 pm
It will, of course, be interesting to see whether the IPO and AIPLA have altered their positions in the past two years. [read post]
31 Dec 2008, 6:04 am
  It is with great thanks that I note those that bring many of the visitors to our site: IP Newsflash Patently-O Orange Book Blog Patent Docs Pharmalot 271 Patent Blog Securing Innovation IP Think Tank AIPLA IP Outline Patent Circle Patent Hawk Genome Technology Online Likelihood of Confusion Above the Law Cafe Pharma Here’s wishing you and yours a great year in 2009! [read post]
14 Oct 2006, 10:05 am
AIPLA amicus brief supporting Figueroa at the Court of Federal Claims. [read post]
16 Jun 2009, 3:31 am
  The faculty for the event is very impressive, including the following confirmed speakers: Marshall Phelps, Corporate VP for IP Policy and Strategy, Microsoft Ruud Peters, CEO, Philips IP & Standards Carl Horton, Chief IP Counsel, GE Scott Frank, President and CEO, AT&T Intellectual Property Todd Dickinson, Executive Director, AIPLA Ciarán McGinley, Head of the Controlling Office, European Patent Office Beatrix de… [read post]
16 Jul 2007, 8:23 pm
AIPLA’s amicus brief supports Bilski and a broad interpretation of patentable subject matter. [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA. [read post]
31 Oct 2015, 5:27 am by Dennis Crouch
 Thus, I expect that any IPO/AIPLA (and probably PTO) commentary on this front will support the current automatic-assignment rule. **** * I included the asterisk next to “moment” of invention because of the reality that invention is typically a process distributed over time. [read post]
13 Apr 2011, 6:26 am by Matt Osenga
Predictably, AIPLA and similar organizations are again outraged. [read post]
9 Feb 2009, 1:28 am
On Friday, the Coalition for 21st Century Patent Reform, formally issued a paper (presented earlier at meetings of the AIPLA and ACPC) arguing that the fast pace of change in patent law made the courts more suitable for change.The paper is titled "Reform of a Fast-Moving Target: The Development of Patent Law Since the 2004 National Academies Report", written by litigator William C. [read post]
2 Jun 2009, 4:00 am
•    Damon Matteo, PARC •    Carl Horton, GE •    Sherry Knowles, GSK •    Peter Cicala, Shire Pharmaceuticals •    Todd Dickinson, AIPLA •    Ruud Peters, Philips IP & Standards •    Marshall Phelps, Microsoft … [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA. [read post]
7 Aug 2010, 4:46 am by Dennis Crouch
Court Decisions: District Court Opinion Original Panel Decision En Banc Order Party Briefs: TheraSense (Abbott) Opening Brief: TheraSense.pdf (608 KB) Amicus Brief filed in Support of TheraSense Sanofi-Aventis and Microsoft: AventisMicrosoft.pdf (791 KB) Ole Nilssen: Nilssen.pdf (1608 KB) Amici Briefs filed in Support of Neither Party Apotex: Apotex.pdf (904 KB)  United States Patent & Trademark Office (USPTO): USPTO.pdf (770 KB) Intellectual Property Owners Association… [read post]